[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE8006861L - Cefalosporinantibiotika - Google Patents

Cefalosporinantibiotika

Info

Publication number
SE8006861L
SE8006861L SE8006861A SE8006861A SE8006861L SE 8006861 L SE8006861 L SE 8006861L SE 8006861 A SE8006861 A SE 8006861A SE 8006861 A SE8006861 A SE 8006861A SE 8006861 L SE8006861 L SE 8006861L
Authority
SE
Sweden
Prior art keywords
pentahydrate
cephalosporin antibiotics
crystalline
pyridiniummethyl
carboxyprop
Prior art date
Application number
SE8006861A
Other languages
Unknown language ( )
English (en)
Other versions
SE449614B (sv
Inventor
A C Brodie
L A Wetherill
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8006861L publication Critical patent/SE8006861L/sv
Publication of SE449614B publication Critical patent/SE449614B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8006861A 1979-10-02 1980-10-01 (6r,7r)-7-/(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxiimino)acetamido/-3-(1-pyridiniummetyl)cef-3-em-4-karboxylatpentahydrat, forfarande for dess framstellning och farmaceutisk komposition derav SE449614B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7934204 1979-10-02

Publications (2)

Publication Number Publication Date
SE8006861L true SE8006861L (sv) 1981-04-03
SE449614B SE449614B (sv) 1987-05-11

Family

ID=10508246

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8006861A SE449614B (sv) 1979-10-02 1980-10-01 (6r,7r)-7-/(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxiimino)acetamido/-3-(1-pyridiniummetyl)cef-3-em-4-karboxylatpentahydrat, forfarande for dess framstellning och farmaceutisk komposition derav

Country Status (36)

Country Link
US (1) US4329453A (sv)
JP (1) JPS5657791A (sv)
KR (1) KR840001776B1 (sv)
AT (1) AT368161B (sv)
AU (1) AU539519B2 (sv)
BE (1) BE885489A (sv)
BG (1) BG33586A3 (sv)
CA (1) CA1142919A (sv)
CH (1) CH645118A5 (sv)
CS (1) CS214721B2 (sv)
CY (1) CY1338A (sv)
DD (1) DD153376A5 (sv)
DE (1) DE3037102C2 (sv)
DK (1) DK155525C (sv)
EC (1) ECSP941099A (sv)
ES (1) ES8106908A1 (sv)
FI (1) FI71157C (sv)
FR (1) FR2466467A1 (sv)
GB (1) GB2063871B (sv)
GR (1) GR69123B (sv)
HK (1) HK78686A (sv)
HU (1) HU184835B (sv)
IT (1) IT1144006B (sv)
KE (1) KE3641A (sv)
MX (1) MX6545E (sv)
MY (1) MY8500315A (sv)
NL (1) NL190329C (sv)
NO (1) NO156246C (sv)
PL (1) PL126606B1 (sv)
PT (1) PT71860B (sv)
RO (1) RO82721B (sv)
SE (1) SE449614B (sv)
SU (1) SU942599A3 (sv)
UA (1) UA7208A1 (sv)
YU (1) YU42357B (sv)
ZA (1) ZA806081B (sv)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4427677A (en) 1980-12-31 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4394503A (en) 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives
US4474954A (en) * 1981-12-07 1984-10-02 Bristol-Myers Company Intermediates for cephalosporin derivatives
JPS58198489A (ja) * 1982-05-14 1983-11-18 Meiji Seika Kaisha Ltd 7β−(2D−2−アミノ−2−カルボキシエチルチオアセトアミド)−7α−メトキシ−3−(1−メチル−1H−テトラゾ−ル−5−イル)−チオメチル−3−セフエム−4−カルボン酸ナトリウム塩の七水和物及びその製造方法
ES8502863A1 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
JPS60231683A (ja) * 1984-05-02 1985-11-18 Teijin Ltd セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤
US4616080A (en) * 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate
US4626534A (en) * 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
IL75800A (en) * 1984-07-23 1988-11-30 Lilly Co Eli Pharmaceutical formulations comprising ceftazidime pentahydrate and amorphous lactose
ATE60607T1 (de) * 1984-11-08 1991-02-15 Lilly Co Eli Verfahren zur herstellung von kristallinischem ceftazidime-pentahydrat.
US4659813A (en) * 1984-11-08 1987-04-21 Eli Lilly And Company Crystallization process for ceftazidime derivative
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4994451A (en) * 1988-01-19 1991-02-19 Bristol-Myers Company Cephalosporin salts and injectable compositions
US4954624A (en) * 1986-10-07 1990-09-04 Sandoz Ltd. Process for the production of cephalosporin derivatives
AT387390B (de) * 1986-10-07 1989-01-10 Biochemie Gmbh Verfahren zur herstellung des antibiotikums (6r,7r)-7-(2-(2-amino-4-thiazolyl)-2-(2-carboxy
US5021564A (en) * 1987-02-02 1991-06-04 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
JP2533151B2 (ja) * 1987-02-02 1996-09-11 イーライ・リリー・アンド・カンパニー 抗生物質製造の改良法
WO1988010262A1 (fr) * 1987-06-25 1988-12-29 Banyu Pharmaceutical Co., Ltd. Compose cristallin de cephalosporine
KR950010084B1 (ko) * 1987-06-25 1995-09-06 반유세이야꾸 가부시끼가이샤 결정성 세팔로스포린 화합물, 그의 제조법 및 그의 제조 중간체
GB8802622D0 (en) * 1988-02-05 1988-03-02 Glaxo Group Ltd Chemical compound
KR940000112B1 (ko) * 1990-07-05 1994-01-05 주식회사 대웅제약 신규의 3-치환 세펨화합물 및 그의 제조방법
US5831085A (en) * 1997-01-16 1998-11-03 Lupin Laboratories Limited Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof
CN1328281C (zh) * 2004-11-16 2007-07-25 广州白云山制药股份有限公司 头孢他啶的纯化方法
CN102875576A (zh) * 2012-10-31 2013-01-16 苏州致君万庆药业有限公司 一种抗菌素头孢他啶的合成、注射用头孢他啶及其制备方法
CN102924483B (zh) * 2012-10-31 2015-06-17 海南合瑞制药股份有限公司 一种头孢他啶晶体化合物、其制备方法及其无菌混合粉形式的药物组合物
CN104876949A (zh) * 2015-05-28 2015-09-02 浙江长典医药有限公司 一种小儿用头孢他啶化合物实体及其制剂
CN106420658A (zh) * 2016-09-23 2017-02-22 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢他啶胶囊
CN109111467A (zh) * 2017-06-22 2019-01-01 宁应 一种51/4水头孢他啶化合物及其药物组合物制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato

Also Published As

Publication number Publication date
NO156246B (no) 1987-05-11
FI803126L (fi) 1981-04-03
YU249780A (en) 1983-02-28
ES495534A0 (es) 1981-09-01
DD153376A5 (de) 1982-01-06
NL190329B (nl) 1993-08-16
DK155525C (da) 1989-09-04
SU942599A3 (ru) 1982-07-07
FR2466467A1 (fr) 1981-04-10
US4329453A (en) 1982-05-11
HU184835B (en) 1984-10-29
JPH0128036B2 (sv) 1989-05-31
DK155525B (da) 1989-04-17
KR830004317A (ko) 1983-07-09
NL8005443A (nl) 1981-04-06
DK414780A (da) 1981-04-03
CY1338A (en) 1987-01-16
CA1142919A (en) 1983-03-15
PT71860B (en) 1982-04-02
RO82721A (ro) 1984-09-29
SE449614B (sv) 1987-05-11
BE885489A (fr) 1981-04-01
ATA490080A (de) 1982-01-15
AT368161B (de) 1982-09-27
AU6288280A (en) 1981-04-09
IT1144006B (it) 1986-10-29
ZA806081B (en) 1982-05-26
BG33586A3 (en) 1983-03-15
PT71860A (en) 1980-11-01
PL227019A1 (sv) 1981-06-05
CH645118A5 (de) 1984-09-14
YU42357B (en) 1988-08-31
MY8500315A (en) 1985-12-31
RO82721B (ro) 1984-10-30
FR2466467B1 (sv) 1984-02-10
NO802913L (no) 1981-04-03
NL190329C (nl) 1994-01-17
IT8049783A0 (it) 1980-10-01
CS214721B2 (en) 1982-05-28
AU539519B2 (en) 1984-10-04
KR840001776B1 (ko) 1984-10-19
UA7208A1 (uk) 1995-06-30
DE3037102A1 (de) 1981-04-23
KE3641A (en) 1986-07-11
NO156246C (no) 1987-08-19
MX6545E (es) 1985-07-10
GB2063871B (en) 1983-06-02
GB2063871A (en) 1981-06-10
HK78686A (en) 1986-10-24
ES8106908A1 (es) 1981-09-01
FI71157C (fi) 1986-11-24
PL126606B1 (en) 1983-08-31
ECSP941099A (es) 1995-01-16
GR69123B (sv) 1982-05-03
JPS5657791A (en) 1981-05-20
FI71157B (fi) 1986-08-14
DE3037102C2 (de) 1986-04-10

Similar Documents

Publication Publication Date Title
SE8006861L (sv) Cefalosporinantibiotika
SE8006860L (sv) Cefalosporinantibiotika
AR228726A1 (es) Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
IE782546L (en) Amino-thiazolyl cephalosporins
AU5137373A (en) Pencillin and cephalosporin compounds
SE7909401L (sv) Cefalosporinantibiotika
SE8003429L (sv) Heterocyklylderivat av oxi-imino-substituerade cefalosporiner samt forfarande for framstellning derav
AU571506B2 (en) Cristalline ceftazidime
SE7706081L (sv) Forfarande for framstellning av cefalosporiner
SE7603165L (sv) Antibiotikum
SE8001423L (sv) Cefalosporinantibiotika
ES2072293T3 (es) Solvatos del diclorhidrato de ceftazidima con acido formico.
SE8002217L (sv) Cefalosporinantibiotika
ES461691A1 (es) Un procedimiento para la preparacion de sales de compuestos.
IE45982L (en) MONOCYCLIC ß-LACTAMS WITH ANTIBACTERIAL ACTIVITY.
ATE31535T1 (de) Cephalosporinverbindungen.
ES8501768A1 (es) Procedimiento para preparar (6r, 7r)-7-( (z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oximino)-acetamido)-3-(1-piridiniometil)-cef-3-em-carboxilato x 1, 5 moles de agua, cristalizado
ATE82977T1 (de) Kristalline cephalosporinderivate.
FR2338046A2 (fr) Nouvelles cephalosporines, leur procede de preparation et leur application en therapeutique
BE770635Q (en) Antibiotic 3-mercaptothiazole- or 3-mercap- - totetrazolecephalosporins

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8006861-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8006861-2

Format of ref document f/p: F